Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study

Emerging evidence supports a prognostic role of primary tumor location in metastatic colon cancer (mCC). We conducted a retrospective analysis to evaluate the effect of tumor location on prognosis and efficacy of biological agents (anti-EGFR, Cetuximab and Panitumumab, or anti-VEGF, Bevacizumab) add...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Cancer
Main Authors: Grassadonia, Antonino, Di Marino, Pietro, Ficorella, Corrado, Cortellini, Alessio, Cannita, Katia, Parisi, Alessandro, Gamucci, Teresa, Zoratto, Federica, Vici, Patrizia, Barba, Maddalena, Porreca, Ettore, Neri, Matteo, Veronese, Angelo, Natoli, Clara, De Tursi, Michele, Tinari, Nicola
פורמט: Artigo
שפה:Inglês
יצא לאור: Ivyspring International Publisher 2019
נושאים:
Research Paper
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6856567/
https://ncbi.nlm.nih.gov/pubmed/31762802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.34550
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים